Best TWAS P=3.07e-11 · Best GWAS P=1.2e-13 conditioned to 0.111
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adrenal Gland | CD22 | 0.35 | 0.17 | enet | 17 | 0.25 | 2.5e-09 | 4.9 | 5.8 | 8.6e-09 | 0.48 | 0.88 | 0.07 | FALSE |
2 | GTEx | Artery Coronary | LSR | 0.23 | 0.21 | enet | 6 | 0.22 | 5.6e-08 | -5.6 | -5.2 | 1.5e-07 | -0.63 | 0.19 | 0.71 | FALSE |
3 | GTEx | Artery Tibial | CD22 | 0.17 | 0.15 | lasso | 4 | 0.14 | 9.5e-11 | 5.3 | 5.8 | 6.8e-09 | 0.56 | 0.99 | 0.00 | FALSE |
4 | GTEx | Colon Sigmoid | CD22 | 0.23 | 0.11 | lasso | 2 | 0.11 | 1.3e-04 | 5.3 | 5.6 | 2.4e-08 | 0.50 | 0.36 | 0.17 | FALSE |
5 | GTEx | Heart Atrial Appendage | CD22 | 0.25 | 0.29 | lasso | 2 | 0.27 | 1.4e-12 | 5.3 | 5.3 | 8.9e-08 | 0.50 | 1.00 | 0.00 | FALSE |
6 | GTEx | Heart Atrial Appendage | ZNF792 | 0.19 | -0.01 | enet | 16 | 0.01 | 1.6e-01 | 2.9 | -5.4 | 7.1e-08 | -0.39 | 0.06 | 0.17 | FALSE |
7 | GTEx | Heart Left Ventricle | CD22 | 0.18 | 0.16 | lasso | 4 | 0.14 | 1.1e-07 | 5.3 | 5.4 | 5.3e-08 | 0.49 | 0.95 | 0.02 | FALSE |
8 | GTEx | Liver | CD22 | 0.39 | 0.14 | enet | 6 | 0.08 | 2.5e-03 | 5.3 | 5.6 | 2.1e-08 | 0.55 | 0.14 | 0.52 | FALSE |
9 | GTEx | Lung | CD22 | 0.24 | 0.12 | enet | 55 | 0.15 | 2.3e-11 | 5.3 | 5.7 | 1.6e-08 | 0.43 | 1.00 | 0.00 | TRUE |
10 | GTEx | Nerve Tibial | CD22 | 0.18 | 0.13 | enet | 24 | 0.12 | 1.1e-08 | 6.2 | 5.9 | 3.2e-09 | 0.55 | 0.79 | 0.21 | FALSE |
11 | GTEx | Pituitary | CD22 | 0.47 | 0.42 | lasso | 3 | 0.46 | 5.6e-13 | 5.3 | 5.4 | 5.4e-08 | 0.49 | 0.95 | 0.03 | FALSE |
12 | GTEx | Thyroid | CD22 | 0.31 | 0.27 | lasso | 4 | 0.30 | 1.5e-23 | 5.3 | 5.3 | 9.7e-08 | 0.51 | 1.00 | 0.00 | FALSE |
13 | GTEx | Uterus | CD22 | 0.57 | 0.41 | lasso | 5 | 0.23 | 1.7e-05 | 5.3 | 5.5 | 4.5e-08 | 0.50 | 0.36 | 0.15 | FALSE |
14 | The Cancer Genome Atlas | Breast Invasive Carcinoma | MAG | 0.04 | 0.06 | lasso | 2 | 0.05 | 1.3e-10 | 5.3 | 5.3 | 8.7e-08 | 0.50 | 1.00 | 0.00 | FALSE |
15 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | MAG | 0.06 | 0.07 | lasso | 1 | 0.07 | 6.3e-08 | 5.3 | 5.3 | 9.9e-08 | 0.50 | 0.96 | 0.03 | FALSE |
16 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CD22 | 0.14 | 0.14 | lasso | 2 | 0.13 | 2.8e-14 | 5.3 | 5.3 | 8.7e-08 | 0.50 | 1.00 | 0.00 | FALSE |
17 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | MAG | 0.48 | 0.30 | enet | 32 | 0.36 | 3.0e-42 | 5.3 | 5.7 | 1.1e-08 | 0.56 | 1.00 | 0.00 | FALSE |
18 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | CD22 | 0.09 | 0.04 | lasso | 1 | 0.01 | 7.8e-02 | 5.3 | 5.3 | 9.9e-08 | 0.50 | 0.02 | 0.30 | FALSE |
19 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | MAG | 0.23 | 0.25 | lasso | 2 | 0.23 | 1.8e-13 | 5.3 | 5.4 | 8.2e-08 | 0.50 | 1.00 | 0.00 | FALSE |
20 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LSR | 0.06 | 0.04 | lasso | 3 | 0.03 | 2.6e-04 | 6.5 | -6.6 | 3.1e-11 | -0.83 | 0.01 | 0.98 | TRUE |
21 | The Cancer Genome Atlas | Lung Adenocarcinoma | MAG | 0.43 | 0.36 | lasso | 7 | 0.36 | 6.3e-44 | 5.3 | 5.5 | 5.2e-08 | 0.49 | 1.00 | 0.00 | FALSE |
22 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | MAG | 0.24 | 0.25 | lasso | 3 | 0.25 | 2.9e-28 | 5.3 | 5.4 | 7.9e-08 | 0.50 | 1.00 | 0.00 | FALSE |
23 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | MAG | 0.32 | 0.23 | lasso | 2 | 0.24 | 2.0e-10 | 5.3 | 5.3 | 1.2e-07 | 0.49 | 0.97 | 0.03 | FALSE |
24 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | CD22 | 0.58 | 0.50 | lasso | 2 | 0.51 | 6.4e-23 | 5.3 | 5.3 | 8.6e-08 | 0.50 | 1.00 | 0.00 | FALSE |
25 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | MAG | 0.56 | 0.48 | lasso | 4 | 0.46 | 2.1e-20 | 5.3 | 5.3 | 8.7e-08 | 0.50 | 1.00 | 0.00 | FALSE |
26 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CD22 | 0.41 | 0.27 | lasso | 4 | 0.27 | 1.9e-28 | 5.3 | 5.8 | 7.9e-09 | 0.46 | 1.00 | 0.00 | FALSE |
27 | The Cancer Genome Atlas | Prostate Adenocarcinoma | MAG | 0.67 | 0.48 | lasso | 6 | 0.47 | 1.3e-55 | 5.3 | 5.4 | 7.0e-08 | 0.50 | 1.00 | 0.00 | FALSE |
28 | The Cancer Genome Atlas | Soft Tissue Sarcoma | MAG | 0.29 | 0.22 | lasso | 3 | 0.23 | 8.6e-14 | 5.3 | 5.4 | 5.8e-08 | 0.50 | 1.00 | 0.00 | FALSE |
29 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | MAG | 0.27 | 0.22 | lasso | 2 | 0.13 | 2.8e-04 | 5.3 | 5.3 | 1.3e-07 | 0.48 | 0.15 | 0.09 | FALSE |
30 | The Cancer Genome Atlas | Stomach Adenocarcinoma | MAG | 0.19 | 0.24 | lasso | 2 | 0.22 | 3.4e-16 | 5.3 | 5.3 | 8.9e-08 | 0.50 | 1.00 | 0.00 | FALSE |
31 | The Cancer Genome Atlas | Thyroid Carcinoma | CD22 | 0.46 | 0.42 | lasso | 4 | 0.44 | 2.3e-46 | 5.3 | 5.5 | 4.7e-08 | 0.52 | 1.00 | 0.00 | FALSE |
32 | The Cancer Genome Atlas | Thyroid Carcinoma | FFAR1 | 0.38 | 0.28 | lasso | 5 | 0.28 | 7.1e-27 | 5.3 | 5.5 | 3.8e-08 | 0.50 | 0.00 | 1.00 | FALSE |
33 | The Cancer Genome Atlas | Thyroid Carcinoma | MAG | 0.63 | 0.50 | lasso | 6 | 0.52 | 6.6e-58 | 5.3 | 5.7 | 1.4e-08 | 0.54 | 1.00 | 0.00 | FALSE |